Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 277

1.
2.

Neuromuscular Electrical Stimulation Can Improve Walking Endurance In Individuals With Multiple Sclerosis: 2573 Board #96 June 3, 9: 30 AM - 11: 00 AM.

Davis LA, Almuklass A, Derquaoi K, Hamilton L, Hebert J, Vollmer TL, Alvarez E, Enoka RM.

Med Sci Sports Exerc. 2016 May;48(5 Suppl 1):713. doi: 10.1249/01.mss.0000487142.45225.54. No abstract available.

PMID:
27361209
3.

Neuromuscular Determinants For Walking Performance In Individuals With Multiple Sclerosis: 2570 Board #93 June 3, 9: 30 AM - 11: 00 AM.

Almuklass A, Davis L, Vieira T, Botter A, Derqaoui KD, Hamilton L, Hebert JR, Vollmer TL, Alvarez E, Enoka RM.

Med Sci Sports Exerc. 2016 May;48(5S Suppl 1):712. No abstract available.

PMID:
27361206
4.

Safety and Tolerability of Delayed-Release Dimethyl Fumarate Administered with Interferon Beta or Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis.

Calkwood J, Vollmer T, Fox RJ, Zhang R, Novas M, Sheikh SI, Viglietta V.

Int J MS Care. 2016 May-Jun;18(3):138-46. doi: 10.7224/1537-2073.2015-020.

5.

Determinants of high cost in multiple sclerosis patients: a claims and chart review study.

Ke X, Navaratnam P, Sasane R, Eisenberg Lawrence DF, Friedman HS, Tulsi BB, Vollmer T.

Curr Med Res Opin. 2016 Jun 25:1-9. [Epub ahead of print]

PMID:
27207562
6.

Assessing the impact of multiple sclerosis disease activity and daclizumab HYP treatment on patient-reported outcomes: Results from the SELECT trial.

Phillips G, Guo S, Bender R, Havrdová E, Proskorovsky I, Vollmer T.

Mult Scler Relat Disord. 2016 Mar;6:66-72. doi: 10.1016/j.msard.2016.02.001. Epub 2016 Feb 1.

PMID:
27063626
7.

Autoimmune encephalitis: A more treatable tragedy if diagnosed early.

Vollmer TL, McCarthy M.

Neurology. 2016 May 3;86(18):1655-6. doi: 10.1212/WNL.0000000000002641. Epub 2016 Apr 1. No abstract available.

PMID:
27037233
8.

Implementation of NAT Screening for West Nile Virus and Experience with Seasonal Testing in Germany.

Dreier J, Vollmer T, Hinse D, Heuser EJ, Pisani G, Knabbe C.

Transfus Med Hemother. 2016 Jan;43(1):28-36. doi: 10.1159/000440833. Epub 2015 Sep 28.

9.

Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD.

Yan Y, Li Y, Fu Y, Yang L, Su L, Shi K, Li M, Liu Q, Borazanci A, Liu Y, He Y, Bennett JL, Vollmer TL, Shi FD.

Sci China Life Sci. 2016 Feb 26. [Epub ahead of print]

PMID:
26920678
10.

Establishment of a proficiency panel for an external quality assessment programme for the detection of bacterial contamination in platelet concentrates using rapid and cultural detection methods.

Vollmer T, Schmidt M, Hourfar K, Schottstedt V, Pichl L, Gubbe K, Knabbe C, Dreier J.

Vox Sang. 2016 May;110(4):336-43. doi: 10.1111/vox.12384. Epub 2016 Feb 5.

PMID:
26848941
11.

Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing-remitting multiple sclerosis.

Radue EW, Sprenger T, Vollmer T, Giovannoni G, Gold R, Havrdova E, Selmaj K, Stefoski D, You X, Elkins J.

Eur J Neurol. 2016 Feb;23(2):412-5. doi: 10.1111/ene.12922.

PMID:
26806217
12.

Optimizing treatment success in multiple sclerosis.

Ziemssen T, Derfuss T, de Stefano N, Giovannoni G, Palavra F, Tomic D, Vollmer T, Schippling S.

J Neurol. 2016 Jun;263(6):1053-65. doi: 10.1007/s00415-015-7986-y. Epub 2015 Dec 24. Review.

13.

Bench Test for the Detection of Bacterial Contamination in Platelet Concentrates Using Rapid and Cultural Detection Methods with a Standardized Proficiency Panel.

Vollmer T, Knabbe C, Geilenkeuser WJ, Schmidt M, Dreier J.

Transfus Med Hemother. 2015 Jul;42(4):220-5. doi: 10.1159/000437396. Epub 2015 Jul 16.

14.

Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review.

Vollmer T, Huynh L, Kelley C, Galebach P, Signorovitch J, DiBernardo A, Sasane R.

Neurol Sci. 2016 Feb;37(2):165-79. doi: 10.1007/s10072-015-2400-1. Epub 2015 Nov 4.

PMID:
26537494
15.

Monitoring of in-hospital cardiac arrest events with the focus on Automated External Defibrillators--a retrospective observational study.

Wurmb T, Vollmer T, Sefrin P, Kraus M, Happel O, Wunder C, Steinisch A, Roewer N, Maier S.

Scand J Trauma Resusc Emerg Med. 2015 Oct 31;23:87. doi: 10.1186/s13049-015-0170-7.

16.

Incorporating real-world clinical practice in multiple sclerosis economic evaluations.

McQueen RB, Nair KV, Vollmer TL, Campbell JD.

Expert Rev Pharmacoecon Outcomes Res. 2015;15(6):869-72. doi: 10.1586/14737167.2015.1081060. Epub 2015 Aug 20.

PMID:
26295727
17.

The natural history of brain volume loss among patients with multiple sclerosis: a systematic literature review and meta-analysis.

Vollmer T, Signorovitch J, Huynh L, Galebach P, Kelley C, DiBernardo A, Sasane R.

J Neurol Sci. 2015 Oct 15;357(1-2):8-18. doi: 10.1016/j.jns.2015.07.014. Epub 2015 Jul 13. Review.

PMID:
26238166
18.

Systematic Evaluation of Different Nucleic Acid Amplification Assays for Cytomegalovirus Detection: Feasibility of Blood Donor Screening.

Vollmer T, Knabbe C, Dreier J.

J Clin Microbiol. 2015 Oct;53(10):3219-25. doi: 10.1128/JCM.01091-15. Epub 2015 Jul 22.

19.

Hepatitis E.

Petrik J, Lozano M, Seed CR, Faddy HM, Keller AJ, Prado Scuracchio PS, Wendel S, Andonov A, Fearon M, Delage G, Zhang J, Shih JW, Gallian P, Djoudi R, Tiberghien P, Izopet J, Dreier J, Vollmer T, Knabbe C, Aggarwal R, Goel A, Ciccaglione AR, Matsubayashi K, Satake M, Tadokoro K, Jeong SH, Zaaijer HL, Zhiburt E, Chay J, Teo D, Chua SS, Piron M, Sauleda S, EchevarrĂ­a JM, Dalton H, Stramer SL.

Vox Sang. 2016 Jan;110(1):93-130. doi: 10.1111/vox.12285. Epub 2015 Jul 21. No abstract available.

PMID:
26198159
20.

Data analysis of response interruption and redirection as a treatment for vocal stereotypy.

Wunderlich KL, Vollmer TR.

J Appl Behav Anal. 2015 Dec;48(4):749-64. doi: 10.1002/jaba.227. Epub 2015 Jul 14.

PMID:
26173813
Items per page

Supplemental Content

Loading ...
Write to the Help Desk